3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
12
Phase 4
7
Phase 3
5
Phase 1/2
4
Phase 2/3
2
Phase 2
2
Phase EARLY_PHASE1
1
Status
Unknown
2
Terminated
1
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Thoracic
1
Conditions
Thoracic Neoplasms
1
Neoplasms
1
Interventions
Cisplatin
20
Docetaxel
19
Capecitabine
19
Oxaliplatin
14
Drug Therapy
14
Cyclophosphamide
14
Paclitaxel
13
Fluorouracil
12
Radiotherapy
11
apatinib
9
Gemcitabine
9
Doxorubicin
9
Decitabine
9
Methotrexate
8
Epirubicin
8
Carboplatin
8
sintilimab
6
Etoposide
6
camrelizumab
5
anlotinib
5
XELOX
5
Sorafenib
5
Radiation
5
Pemetrexed
5
Neoadjuvant Therapy
5
Leucovorin
5
Idarubicin
5
Dexamethasone
5
Cytarabine
5
Busulfan
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Unknown
×
Sodium Chloride
×
Clear all
NCT04209868
2024-03-29
ParaSOL
Guy's and St Thomas' NHS Foundation Trust
Phase 2/3
Unknown
100 enrolled
NCT04741880
2021-07-30
ELSA
Instituto Nacional de Cancer, Brazil
Phase 2/3
Unknown
66 enrolled